Joshua R. Lamstein - 23 Jul 2021 Form 4 Insider Report for Scopus BioPharma Inc.

Role: Chairman, Director
Signature: /s/ Joshua R. Lamstein
Issuer symbol: SCPS on OTC
Transactions as of: 23 Jul 2021
Net transactions value: +$7,065
Form type: 4
Filing time: 27 Jul 2021, 16:59:01 UTC
Next filing: 03 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SCPS	Common Stock, par value $0.001	Purchase	$7,065	+1,500	+1.3%	$4.71^*	118,797	23 Jul 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.